Researchers may have finally answered the question of why many antibodies that target the HIV envelope are still unable to stop the virus from spreading -- a troublesome stumbling block in the ...
UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the ...
As therapeutic antibodies become more complex, where is the field making real progress and which problems are proving hardest ...
In people with severely compromised immune systems, JC polyomavirus can trigger an untreatable, often fatal brain disease. An international research team has identified how virus mutations can ...
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...
Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for cancer therapy. Antibodies are Y-shaped proteins produced by the body’s ...
Researchers discover that the COVID-19 virus can trigger the production of 'abzymes' -- antibodies that act like enzymes -- which may explain why long COVID symptoms persist even after the infection ...
UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results